Navigation Links
FDA Moves to Speed Development of Artificial Pancreas Systems
Date:12/1/2011

o get a safe and effective product on the market quickly."

In type 1 diabetes, the pancreas produces little or no insulin, an essential hormone necessary for controlling blood sugar. People with type 1 diabetes have to monitor their blood sugar throughout the day, and calculate how much insulin they need to lower their blood sugar, which is delivered using a syringe or insulin pump.

An artificial pancreas system combines an insulin pump and a continuous glucose monitor with a sensor placed under the patient's skin. The pump and monitor work together, tracking blood sugar and automatically pumping measured doses of insulin as determined by a computer algorithm.

These systems help eliminate, or reduce the severity of dangerous drops in blood sugar by stopping insulin administration when blood sugar levels near a predetermined threshold.

The device is not a cure, but it might reduce dangerous high and low blood sugar levels, giving patients a better quality of life and reducing the risk of diabetes-related complications, the FDA said.

The new guidelines recommend a three-phase clinical study progression "so that studies may move to an outpatient setting as quickly as possible." The agency is also suggesting other ways to streamline the testing process, including ways to use existing safety and effectiveness data for the components that make up the system, and allowing data from clinical studies done outside of the United States to be used in the approval process.

In addition, those conducting the clinical trials have the option of demonstrating that the system controls blood sugar as well as standard therapies, or showing that it gives better blood sugar control when compared to other therapies.

"When final, the guidance will help manufacturers and investigators assemble submissions for clinical trials as well as product-approval submissions," the FDA said.

In June, the FDA released a draft guidance on safety an
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Medicare Cost-Saving Moves Can Backfire
2. Idaho House Moves State Closer to Health Care Disaster
3. California Moves Toward Listing BPA as Reproductive Toxin
4. Sun Spark Purity Moves Aggressively into the Market of Pure Lidocaine Powder and Caffeine Powder
5. Bella Medspa Moves into New Newtown Bucks County Office
6. LazyTown Sportacus and Michelle Obama moves Washington DC
7. Mind Reading Moves Closer to Reality
8. Recent Studies Show MAstertuck℠ Technique Removes Large Amounts of Body Fat without Tummy Tuck Surgery
9. Artificial Pancreas for Type 1 Diabetes Moves Closer to Reality
10. Recent Book Moves Beyond Defensive Medicine, Tackles Entitlement Reform
11. Astra HR Moves its Corporate Headquarters to King Farm, Rockville, MD
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Moves to Speed Development of Artificial Pancreas Systems 
(Date:5/3/2015)... CA (PRWEB) May 03, 2015 NuevaCare ... MnemeTherapy® at two upcoming area seminars. The first event ... PSA Annual Regional Stroke Conference to be held at ... offered on Wednesday, May 13 during the Dementia Conference ... , “These seminars offer an excellent opportunity to ...
(Date:5/3/2015)... HealthPostures, a pioneering ergonomics company ... at the , May 5 - 7, 2015 Minnesota ... at the conference include its bestselling TaskMate sit stand ... the 6100 TaskMate Executive. Features of the 6100 TaskMate ... tray, extended platform work surface and supply holders. Weighing ...
(Date:5/2/2015)... May 02, 2015 Vancouver fencing company, QS ... provide valuable advice to prospective clients related to their questions ... to install railings around their decks and patios. While that ... that pop up once the person rolls up their sleeve ... installing a railing in finding a gate that matches it. ...
(Date:5/2/2015)... New York, NY (PRWEB) May 02, 2015 ... – when a deadly natural disaster strikes anywhere on ... ways to leverage human sympathy and compassion for their ... US-CERT (United States Computer Emergency Readiness Team) issued ... warning users “of potential email scams citing the earthquake ...
(Date:5/2/2015)... (PRWEB) May 02, 2015 On Tuesday ... City Hospital (ELCH) gathered to celebrate improvements in patient ... Valley Health Partners (RVHP), had zero acquired ventilator associated ... catheter associated infections. ELCH was also recently named a ... management team at ELCH credited the teamwork of staff ...
Breaking Medicine News(10 mins):Health News:NuevaCare Introduces MnemeTherapy® Approach to Care for Elderly Patients with Alzheimer’s, Stroke and Other Types of Neurodegenerative Conditions 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 2Health News:HealthPostures to Appear at the Minnesota Safety and Health Conference 3Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 2Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 3Health News:Cyber Aftershocks from Nepal’s Earthquake Can Cripple Businesses Right Here at Home 4Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2
... Sept. 4 Symmetry Medical Inc.,(NYSE: SMA ... global orthopedic,device industry and other medical markets, announced ... of Specialty Surgical,Instruments (SSI) and Ultra Containers of ... and sterilization containers. About Symmetry Medical Inc. ...
... two drugs shows promise in treating a rare and therapy-resistant ... to other organs, according to a new study led by ... -- decitabine, which can turn on certain genes in cancer ... work together to cause cancer cell death. , Metastatic uveal ...
... that still kills 70,000 every year in developing countries worldwide ... nearly is always fatal when it reaches the brain. ... at Jefferson have shown how a type of bat rabies ... virus reaches the brain, when it is most lethal. They ...
... Novel treatment promotes blood vessel growth in heart muscle, ... A trial testing a genetically engineered treatment in women ... bedevil the millions of Americans with heart disease, ... and Drug Administration. , The study will enroll about ...
... Sept. 4 Martek,s life,sDHA(TM),from microalgae is ... in male,hypertriglyceridemic patients, according to a study ... Journal of Clinical Nutrition. In this study,DHA ... acid), the other omega 3 commonly found ...
... Sept. 4 In a recent New York,Times article ... turn far too quickly to drugs to solve their ... are reasonable measures people can take,first to control a ... or together, can help to lower LDLs." The Soyfoods ...
Cached Medicine News:Health News:Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments 2Health News:Promising drug combination may help those with ocular melanoma that has spread 2Health News:Jefferson immunology researchers halt lethal rabies infection in brain 2Health News:Jefferson immunology researchers halt lethal rabies infection in brain 3Health News:Trial to Test Gene Therapy for Angina in Women 2Health News:Trial to Test Gene Therapy for Angina in Women 3Health News:Study Demonstrates Martek's Algal DHA Oil Improves Blood Triglyceride Lipid Levels 2Health News:Study Demonstrates Martek's Algal DHA Oil Improves Blood Triglyceride Lipid Levels 3Health News:September: Time to Try Cholesterol-Free Soyfoods 2
(Date:5/1/2015)... 2015 Braeburn Pharmaceuticals announced today ... focus beyond addiction and pain to include ... has acquired an implantable, six-month formulation of ... treatment of schizophrenia from Endo Pharmaceuticals. With ... to other potential applications of the implant ...
(Date:5/1/2015)... 2015 Semler Scientific, Inc. (Nasdaq: SMLR ... manufactures and markets products that assist healthcare providers in ... results for the first quarter ended March 31, 2015. ... Semler reported continued progress with year over year growth ... of 14%," said Doug Murphy-Chutorian , M.D., chief ...
(Date:4/30/2015)... 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) ... focus on Omega-3 therapies for cardiovascular disease (CVD) ... financial results for the fiscal year ended December ... in Canadian dollars unless otherwise stated. ... the right strategic partners and additional capitalization in ...
Breaking Medicine Technology:Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 2Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 4Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5Pivotal Therapeutics Announces 2014 Financial Results 2Pivotal Therapeutics Announces 2014 Financial Results 3Pivotal Therapeutics Announces 2014 Financial Results 4Pivotal Therapeutics Announces 2014 Financial Results 5Pivotal Therapeutics Announces 2014 Financial Results 6
... the Millions Still Suffering from Chronic,Hepatitis B and C, ... for Disease,Control and Prevention (CDC) has reported that significant ... the United States,in the last 10 years, reflecting the ... Liver Foundation wants to,highlight these positive results, but remind ...
... tolerability profile Reduction of,testosterone concentration was maintained ... 2b trial, QUEBEC CITY, March 22, 2007 ... Japanese partner Shionogi & Co.,Ltd. today announced ... with,cetrorelix in benign prostatic hyperplasia (BPH) initiated ...
Cached Medicine Technology:The American Liver Foundation Urges Cautious Optimism about CDC,Report on Declining Acute Hepatitis Infection Rates 2The American Liver Foundation Urges Cautious Optimism about CDC,Report on Declining Acute Hepatitis Infection Rates 3AEterna Zentaris Reports Positive Results with Cetrorelix in BPH,for Japanese Phase 2a Trial 2AEterna Zentaris Reports Positive Results with Cetrorelix in BPH,for Japanese Phase 2a Trial 3AEterna Zentaris Reports Positive Results with Cetrorelix in BPH,for Japanese Phase 2a Trial 4
Leica M500 MS3 robotic stand for neuro, spine surgery and ENT. Motorized XY-movement for precise positioning of the optical axis in eight directions, inclination and tilt....
Advanced operating microscope with high-resolution apochromatic optics. Senso-servo drive to keep the microscope in perfect balance even if parts are moved or mounted elsewhere....
Advanced operating microscope with zoom and variable focus up to 500 mm....
... surgeons with brighter, crisper, magnified views of ... many minimally invasive spine procedures. It is ... of contact. The first graphical touchscreen to ... intuitive user guidance similar to that known ...
Medicine Products: